1.5300
+0.3800
+(33.04%)
At close: April 9 at 4:00:03 PM EDT
1.5300
0.00
(0.00%)
Pre-Market: 8:07:59 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.21 | -0.2 | -0.8 | -0.24 |
| Low Estimate | -0.26 | -0.25 | -1 | -0.82 |
| High Estimate | -0.15 | -0.14 | -0.62 | 1.18 |
| Year Ago EPS | -0.25 | -0.48 | -0.98 | -0.8 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 6 |
| Avg. Estimate | 457.8k | 1.17M | 7.03M | 81.93M |
| Low Estimate | -- | 460k | 3.19M | 35M |
| High Estimate | 1.76M | 1.84M | 10M | 293.28M |
| Year Ago Sales | -- | -- | -- | 7.03M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 1,065.72% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.23 | -0.24 | -0.25 | -0.25 |
| EPS Actual | -0.25 | -0.48 | -0.26 | -0.21 |
| Difference | -0.02 | -0.24 | -0.01 | 0.05 |
| Surprise % | -9.65% | -102.81% | -4.98% | 18.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.21 | -0.2 | -0.8 | -0.24 |
| 7 Days Ago | -0.21 | -0.2 | -0.8 | -0.24 |
| 30 Days Ago | -0.25 | -0.25 | -0.87 | -0.09 |
| 60 Days Ago | -0.25 | -0.25 | -0.87 | -0.06 |
| 90 Days Ago | -0.25 | -0.23 | -0.84 | -0.02 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 3 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HUMA | 17.72% | 58.85% | 17.79% | 70.40% |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 3/31/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/28/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/26/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/12/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/7/2025 |
| Reiterates | Benchmark: Buy to Buy | 2/27/2025 |
Related Tickers
ALDX Aldeyra Therapeutics, Inc.
1.9400
+1.04%
HEPA Hepion Pharmaceuticals, Inc.
0.4878
+18.98%
PHIO Phio Pharmaceuticals Corp.
1.5400
+52.48%
SGMO Sangamo Therapeutics, Inc.
0.6987
+11.29%
BDRX Biodexa Pharmaceuticals Plc
1.5100
+7.09%
OSRH OSR Holdings, Inc.
1.5300
+2.00%
ZVSA ZyVersa Therapeutics, Inc.
1.0300
-18.90%
SANA Sana Biotechnology, Inc.
1.5500
+15.67%
IBO Impact BioMedical Inc.
0.5184
-20.25%
LXRX Lexicon Pharmaceuticals, Inc.
0.4909
-2.04%